ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2013

Oct 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2013-10-11

Reporting Person: McKenney Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-11	Common Stock	A	1200	$7.58	Acquired	2220	Direct